ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag office politics microbiology culture

Genome Project Ethics Office Is Achieving New Prominence In National Policy Debates
Franklin Hoke | Oct 2, 1994 | 8 min read
Sidebar:Active and Recently Completed NIH ELSI Research Projects With passage of time and increasing political relevance, HGP branch's influence is on the rise among decision-makers Beginning this year, the component of the United States human genome initiative that has been sponsoring studies of the ethical, legal, and social implications of the massive genome effort's ground-breaking research will be reporting the first hard resul
Genome Project Ethics Office Is Achieving New Prominence In National Policy Debates
Franklin Hoke | Oct 2, 1994 | 8 min read
Sidebar:Active and Recently Completed NIH ELSI Research Projects With passage of time and increasing political relevance, HGP branch's influence is on the rise among decision-makers Beginning this year, the component of the United States human genome initiative that has been sponsoring studies of the ethical, legal, and social implications of the massive genome effort's ground-breaking research will be reporting the first hard resul
Scientific Societies Respond to Trump Immigration Order
Joshua A. Krisch | Feb 1, 2017 | 2 min read
More than 150 scientific societies have objected to the new president’s executive order, arguing that it will hinder international collaboration and make America less competitive
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Sharing the Bounty
Michelle G. Rooks and Wendy S. Garrett | Aug 1, 2011 | 10+ min read
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
NIH's Healy: Although Her Impact Has Been Powerful, Questions Remain About Her Long-Term Influence
Franklin Hoke | Apr 18, 1993 | 8 min read
Praise for some of her achievements is tempered by ongoing concern over future NIH strategies What will be the long-term impact of Bernadine Healy's brief two years as the first woman director of the National Institutes of Health? With her recently announced resignation, effective June 30, the fate of projects and issues she has pressed for or influenced becomes less clear. Among these are her creation of a women's health office at the institutes, her development of a strategic plan for NIH re
Biological Terrorism
Jennifer Fisher Wilson | Nov 11, 2001 | 8 min read
One warning came in black-and-white in 1993: A U.S. Congressional Office of Technology Assessment report projected that releasing 100 kilograms of aerosolized anthrax spores upwind of the U.S. capital could kill between 130,000 and 3 million people-a lethality at least matching that of a hydrogen bomb. Last year, a U.S. Justice Department exercise revealed that discharging pneumonic plague in Denver could create 3,700 or more cases, with an estimated 950 or more deaths within a week.1 Then, acco
AIDS 20 Years Later...
Myrna Watanabe | Jun 10, 2001 | 10+ min read
On June 5, 1981, a one-and-a-half page paper in Morbidity and Mortality Weekly Report (MMWR) noted cases of Pneumocystis carinii pneumonia in five gay men in Los Angeles. The men also suffered from cytomegalovirus (CMV) infections and candidal infections of the mucosa,1 and they used recreational inhalant drugs. The editorial note pointed out: "Pneumocystis pneumonia in the United States is almost exclusively limited to severely immunosuppressed patients." "I was sitting in my office in Buildi
Fascinated by Folding
Anna Azvolinsky | Aug 3, 2017 | 10 min read
Lila Gierasch uses biochemical tools to understand how linear chains of amino acids turn into complex three-dimensional structures.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

Run a Search

ADVERTISEMENT